Crosslinking

The Corneal Cross-Linking Procedure is a groundbreaking treatment designed to halt the progression of keratoconus and corneal ectasia. These conditions cause the cornea to weaken and bulge, leading to blurred or distorted vision.

During the procedure, vitamin B2 (riboflavin) drops are applied to the eye and activated with a controlled ultraviolet (UV) light. This process strengthens the corneal fibers, stabilizing the cornea and protecting vision. Cross-linking does not cure keratoconus, but it is the only proven treatment that stops it from worsening.

Benefits of the Cross-Linking Procedure:

• Stops progression of keratoconus – Protects against further vision loss.

• Strengthens the cornea – Improves corneal stability and durability.

• Preserves vision – Helps patients maintain functional sight and delay or avoid the need for corneal transplantation.

• Safe and effective – FDA-approved and widely performed worldwide.

• Quick outpatient procedure – Minimal downtime and recovery.